Prevention Guide - Safe Handling of Hazardous Drugs - Irsst
Prevention Guide - Safe Handling of Hazardous Drugs - Irsst
Prevention Guide - Safe Handling of Hazardous Drugs - Irsst
You also want an ePaper? Increase the reach of your titles
YUMPU automatically turns print PDFs into web optimized ePapers that Google loves.
10. ADMINISTRATION OF DRUGS<br />
if a one-way valve prevents the use <strong>of</strong> this technique, dilute the hazardous<br />
drug by using a syringe to inject 10 mL <strong>of</strong> compatible solution into the<br />
injection plug closest to the primary tubing (Figure 21). Do not withdraw the<br />
syringe and discard everything with the primary tubing.<br />
Compatible<br />
solution<br />
Drug<br />
bag<br />
Primary<br />
tubing<br />
Disconnection<br />
site<br />
Secondary<br />
tubing<br />
Area to be<br />
rinsed<br />
Toward<br />
the patient<br />
FIGURE 21<br />
Rinsing the tubing with a syringe<br />
<br />
APES, p. 5-28 ♦ ASHP, p. 1189 ♦ CS, p. 68 ♦ CSHP, Section 8.8 ♦ NIOSH, p. 14 ♦ ONS, p. 24 ♦<br />
OSHA, Section Vc2<br />
10.3.8 Subcutaneous or Intramuscular Administration RATING: +++<br />
Use an administration technique that limits exposure risks.<br />
RECOMMENDATIONS<br />
NOTE<br />
The recommendations applicable to the General Administration Measures Section (i.e.,<br />
Section 10.3.4) should be complied with.<br />
10.3.8.1 Workers administering the drugs should place a disposable, absorbent, plastic-backed pad<br />
on the work table for the containers; this pad will also absorb any contamination.<br />
Avoiding pushing on the plunger, remove the protective cap from the syringe over the<br />
absorbent pad.<br />
10.3.8.2 Insert the needle without removing the air.<br />
10.3.8.3 Workers administering the drugs should use handling and administration techniques that<br />
minimize exposure risks:<br />
‣ a Z technique may be used for intramuscular administration <strong>of</strong> the drug (unless there is<br />
insufficient muscle mass – e.g. children), to reduce the risk <strong>of</strong> leaking. To use this<br />
technique, stretch the skin at the injection site at least 2 cm laterally, insert the needle<br />
at a 90 o angle into the area where the skin is stretched and inject the drug at a rate <strong>of</strong> 1<br />
mL every 10 seconds, in order to allow the muscle fibres to dilate and absorb the<br />
solution. Wait 10 seconds after completing the injection to allow the drug to diffuse<br />
into the muscle. Finally, quickly withdraw the needle and allow the skin to move back<br />
10-10 ASSTSAS PREVENTION GUIDE – SAFE HANDLING OF HAZARDOUS DRUGS